Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05298202 · ClinicalTrials.gov registry record · Phase 4
The Influence of Capsaicin Gel During Exercise Within the Heat
A Phase 4 study, sponsored by University of Nebraska.
- Completed
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT05298202 is a Phase 4 study that has completed, run by University of Nebraska. The registered enrollment target is 12 participants.
The verdict
NCT05298202, a Phase 4 study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the human thermoregulatory impact of applying a commercially available capsaicin gel to the skin prior to moderate intensity walking under heated conditions. Experimental Visits will consist of 30 min of treadmill walking at a moderate pace (3.5 mph, 5% grade) under hot conditions (38°C, 60%RH) and will be randomized and counterbalanced for capsaicin gel or a hypoallergenic gel (control) application. Gels will be applied to areas commonly exposed during outdoor activity in warm conditions (shoulder to wrist, mid thigh to ankle). Accordingly, participants will wear shorts and a tank top shirt during exercise. Core temperature, skin temperature, galvanic skin response, laser doppler blood flow, and heart rate will be continuously recorded throughout the exercise bout via an integrated analog to digital converter. Sweat will be collected during exercise using commercially available absorbent patches. Thermal sensation will be assessed throughout exercise via the American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE) thermal sensation likert scale (cold to hot). Lastly, nude body weight will be recorded pre and post exercise for sweat rate determination. The capsaicin and control trials will be separated by a 7-14 day washout period
Interventions
- OTHER Exercise
- BIOLOGICAL Capsaicin
- BIOLOGICAL Control Gel
- OTHER Hot environment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-05-25 |
| Est. Completion | 2022-10-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05298202
The ClinicalTrials.gov registry entry for NCT05298202 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Exercise is the first listed.
NCT05298202 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05298202 about?
NCT05298202 is a clinical study titled "The Influence of Capsaicin Gel During Exercise Within the Heat". The purpose of this study is to examine the human thermoregulatory impact of applying a commercially available capsaicin gel to the skin prior to moderate intensity walking under heated conditions. Experimental Visits will consist of 30 min of treadmill walking at a moderate pace (3.5 mph, 5% grade)...
What is the current status of trial NCT05298202?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2022-05-25. Estimated completion is 2022-10-01.
What interventions are being tested in trial NCT05298202?
The interventions under investigation include: Exercise (OTHER), Capsaicin (BIOLOGICAL), Control Gel (BIOLOGICAL), Hot environment (OTHER).
Who is sponsoring clinical trial NCT05298202?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.